Central Trust Company’s Merck MRK Stock Holding History

Central Trust Company’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.3M	Buy	110,805 +1,613	+1%	+$186K	0.26%	68
2025 Q4	$11.5M	Sell	109,192 -790	-0.7%	-$74.2K	0.23%	76
2025 Q3	$9.23M	Sell	109,982 -2,858	-3%	-$235K	0.19%	89
2025 Q2	$8.93M	Sell	112,840 -4,394	-4%	-$349K	0.21%	87
2025 Q1	$10.5M	Sell	117,234 -5,730	-5%	-$535K	0.26%	73
2024 Q4	$12.2M	Sell	122,964 -14,133	-10%	-$1.46M	0.3%	65
2024 Q3	$15.6M	Sell	137,097 -3,263	-2%	-$388K	0.36%	58
2024 Q2	$17.4M	Sell	140,360 -4,374	-3%	-$563K	0.43%	51
2024 Q1	$19.1M	Sell	144,734 -1,022	-0.7%	-$126K	0.48%	46
2023 Q4	$15.9M	Buy	145,756 +1,333	+0.9%	+$138K	0.42%	48
2023 Q3	$14.9M	Buy	144,423 +3,168	+2%	+$341K	0.43%	49
2023 Q2	$16.3M	Buy	141,255 +9,837	+7%	+$1.12M	0.45%	48
2023 Q1	$14M	Buy	131,418 +10	+0%	+$1.08K	0.41%	51
2022 Q4	$14.6M	Buy	131,408 +3,097	+2%	+$317K	0.45%	49
2022 Q3	$11.1M	Buy	128,311 +6,307	+5%	+$563K	0.38%	58
2022 Q2	$11.1M	Buy	122,004 +4,198	+4%	+$372K	0.37%	59
2022 Q1	$9.67M	Sell	117,806 -3,140	-3%	-$248K	0.28%	73
2021 Q4	$9.27M	Sell	120,946 -1,951	-2%	-$155K	0.26%	83
2021 Q3	$9.23M	Sell	122,897 -3,823	-3%	-$291K	0.33%	72
2021 Q2	$9.86M	Sell	126,720 -17,890	-12%	-$1.33M	0.36%	67
2021 Q1	$10.6M	Sell	144,610 -11,502	-7%	-$848K	0.42%	56
2020 Q4	$12.2M	Sell	156,112 -8,654	-5%	-$662K	0.5%	47
2020 Q3	$13M	Buy	164,766 +8,764	+6%	+$686K	0.59%	42
2020 Q2	$11.5M	Buy	156,002 +6,881	+5%	+$518K	0.58%	43
2020 Q1	$10.9M	Buy	149,121 +11,577	+8%	+$910K	0.67%	37
2019 Q4	$11.9M	Buy	137,544 +4,763	+4%	+$391K	0.61%	40
2019 Q3	$10.7M	Buy	132,781 +11,711	+10%	+$939K	0.6%	39
2019 Q2	$9.36M	Sell	121,070 -2,495	-2%	-$191K	0.53%	43
2019 Q1	$9.81M	Sell	123,565 -414	-0.3%	-$31K	0.58%	40
2018 Q4	$9.04M	Buy	123,979 +995	+0.8%	+$70.2K	0.6%	38
2018 Q3	$8.32M	Buy	122,984 +2,725	+2%	+$174K	0.48%	50
2018 Q2	$6.96M	Sell	120,259 -6,554	-5%	-$370K	0.44%	50
2018 Q1	$6.59M	Buy	126,813 +55	+0%	+$2.97K	0.42%	57
2017 Q4	$6.81M	Buy	126,758 +2,820	+2%	+$156K	0.41%	61
2017 Q3	$7.57M	Sell	123,938 -378	-0.3%	-$22.9K	0.49%	55
2017 Q2	$7.6M	Sell	124,316 -194	-0.2%	-$11.8K	0.5%	50
2017 Q1	$7.55M	Sell	124,510 -5,282	-4%	-$320K	0.5%	51
2016 Q4	$7.29M	Buy	129,792 +847	+0.7%	+$49.6K	0.5%	52
2016 Q3	$7.68M	Buy	128,945 +5,404	+4%	+$316K	0.56%	47
2016 Q2	$6.79M	Buy	123,541 +30	+0%	+$1.6K	0.51%	53
2016 Q1	$6.24M	Buy	123,511 +2,355	+2%	+$115K	0.49%	53
2015 Q4	$6.11M	Sell	121,156 -395	-0.3%	-$19.9K	0.5%	56
2015 Q3	$5.73M	Sell	121,551 -1,199	-1%	-$63.7K	0.5%	54
2015 Q2	$6.67M	Sell	122,750 -1,827	-1%	-$102K	0.52%	48
2015 Q1	$6.83M	Buy	124,577 +12,305	+11%	+$697K	0.55%	45
2014 Q4	$6.08M	Buy	112,272 +5,578	+5%	+$311K	0.5%	51
2014 Q3	$6.04M	Buy	106,694 +1,695	+2%	+$95.2K	0.48%	51
2014 Q2	$5.8M	Sell	104,999 -1,262	-1%	-$68.8K	0.46%	55
2014 Q1	$5.76M	Buy	106,261 +387	+0.4%	+$20K	0.48%	54
2013 Q4	$5.06M	Sell	105,874 -10,013	-9%	-$458K	0.42%	54
2013 Q3	$5.26M	Buy	115,887 +2,268	+2%	+$104K	0.48%	52
2013 Q2	$5.04M	Buy	+113,619	New	+$5.07M	0.48%	55

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Central Trust Company's MRK Position: Q1 2026 in Review

Central Trust Company increased its Merck (MRK) stake by 1.5% in Q1 2026, buying an estimated $186K and bringing the position to 110,805 shares worth $13.3M. The position accounts for 0.26% of the portfolio, ranked #68.

Central Trust Company first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.1M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Central Trust Company held 110,805 shares of Merck worth $13.3M as of Q1 2026.
Central Trust Company bought 1,613 Merck shares in Q1 2026, an estimated $186K.
Merck made up 0.26% of Central Trust Company's portfolio in Q1 2026, its #68 holding.
Central Trust Company first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Central Trust Company's Merck position peaked at $19.1M in Q1 2024.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.